NCT04357795View on ClinicalTrials.gov

Effect of Cequa™ in Subjects With Dry Eye Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

June 24, 2022

Study Completion Date

June 24, 2022

Conditions
Dry Eye Disease
Interventions
DRUG

CequaTM (Cyclosporine 0.09%) ophthalmic solution

One drop CequaTM (Cyclosporine 0.09%) ophthalmic solution in each eye twice daily, approximately 12 hours apart.

Trial Locations (5)

32256

Bowden Eye and Associates, 7205 Bonneval Road, Jacksonville

32405

Eye Center of N Florida, 2500 Martin Luther King Jr Blvd, Panama City

33901

Eye Associates of Fort Myers, 4225 Evans Ave., Fort Myers

66762

Kannarr Eye Care, 2521 N Broadway, Pittsburg

76054

Texas Eye and Laser Center, 1872 Norwood Dr. #200, Hurst

All Listed Sponsors
lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT04357795 - Effect of Cequa™ in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter